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Background: Diabetic retinopathy (DR) is one of the leading causes of blindness in adults in industrialized
countries and the emerging cause of blindness in developing countries. The objective of this study was to describe
the prevalence of DR and risk factors associated with it among diabetic patients.
Methods: The analytical cross-sectional survey and eye screenings were carried out among 625 diabetic patients
from urban and rural areas of Gegharkunik region. DR was assessed by dilated ophthalmoscopy and defined based
on the WHO International Classification of Diseases. The survey instrument, included questions about demographics,
disease history, health status, medication use and healthy lifestyle. Descriptive statistics and logistic regression were
used to analyze the data.
Results: The prevalence of DR in the sample was 36.2%. A total of 90.2% of patients with DR had non-proliferative,
while 9.8% had proliferative DR. In bivariate analysis, age, diabetes duration, being under insulin treatment, blood
glucose level, having non-communicable diseases were significantly associated with DR. In the adjusted analysis
being under insulin treatment (OR = 3.24; 95% CI: 1.56–6.75), diabetes duration (OR = 1.23; 95% CI: 1.16–1.31) and
age (OR = 1.05; 95% CI: 1.02–1.08) were independently associated with DR.
Conclusion: Earlier diagnosis of diabetes and DR can help to control some of these factors and prevent further
complications and vision loss. Population-based educational programs on diabetes and diabetic retinopathy and
continuous medical education on diabetes management can improve diabetes care and self-management and
prevent eye complications.
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Visual impairment and blindness are major public health
problems causing significant suffering, disability, loss of
productivity, and diminishing quality of life for millions
of people. Vision disability is one of the top 10 disabil-
ities among adults 18 years and older worldwide [1].
Age-related blindness is increasing throughout the
world, as is blindness due to uncontrolled diabetes [2].* Correspondence: aida@aua.am
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unless otherwise stated.Uncontrolled hyperglycaemia in diabetic patients can
lead to significant and widespread pathological changes,
including damage to the retina, brain and kidney [3].
After 15 years of diabetes, approximately 2% of people
become blind, and about 10% develop severe visual
impairment [4]. After 20 years, more than 75% of pa-
tients will have some form of diabetic retinopathy [5].
Diabetic retinopathy (DR) is a well-recognized compli-
cation of diabetes mellitus that occurs as a result of
long-term accumulated damage to the small blood ves-
sels in the retina [4,5].
Diabetic retinopathy (DR) is one of the leading causes
of blindness in adults of working age (20 to 65 years) in. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ness in developing countries [3,4]. More than 2.5 million
people worldwide are affected by DR. Clinical trials have
shown that good control of diabetes and hypertension
significantly reduces the risk for diabetic retinopathy [5].
If DR has already developed, timely treatment of retin-
opathy can reduce the risk for visual loss by more than
90%; however, the awareness among patients with dia-
betes about diabetic retinopathy is limited, and compli-
ance with treatment is often poor [5].
The strongest risk factors for DR that are consistently
described in the literature include diabetes duration
[6-12], glycemic control [13-15], insulin treatment
[6,11,12,15] and hypertension [7-9,16-18]. Associations
of DR with type of diabetes [3,9,19], age [9,12,16,17], age
at diabetes onset [6,9], high levels of serum cholesterol
and /or triglycerides [12,16], obesity [8,13], smoking
[7,9], physical activity [20,21] and gender [7,17] have also
been documented [3,6-9,12,13,16,17,19]. Since some of
the risk factors are modifiable, regular screenings for
these factors in people with diabetes might help to de-
velop timely management strategies and reduce compli-
cations and vision loss.
Diabetes-related morbidity, disability and mortality are
growing public health concerns in Armenia. According
to the World Health Organization (WHO) the diabetes
mortality rate in Armenia was 46.5 deaths per 100 000
population in 2009 [22]. According to the International
Diabetes Federation (IDF) estimates, the diabetes mor-
bidity rate is projected to increase by 0.9% annually in
Armenia from 2010 to 2030; which means every tenth
citizen in Armenia would have diabetes in 2030 [22].
Studies of prevalence and risk factors for different eye
pathologies in Armenia are scarce. The only study that
investigated the prevalence and risk factors associated
with different eye conditions in Armenia was conducted
in 2004 by Garo Meghrigian Institute for Preventive
Ophthalmology (GMIPO) [23]. The population based
study of people 50 years old and over showed that 3.7%
were blind with 0.5% having bilateral blindness, and
3.2% unilateral [23]. The main causes of blindness and
visual impairment were cataract, glaucoma, diabetic
retinopathy (9.1% of all bilateral blind cases) and uncor-
rected refractive errors [23]. The overall prevalence of
diabetic retinopathy was 0.7% among the screened
population.
The main obstacles for effective diabetes management
in the country were the limited supply of anti-diabetic
drugs, which placed a heavy financial burden on diabetes
patients; changes in the types and brands of the anti-
diabetic drugs, which lead to destabilization of patients’
blood glucose level; high price of hospital care and ad-
vanced laboratory testing; lack of access to consumables
(glucometers, strips and syringes) and patients’ lack ofknowledge which significantly reduce the effectiveness of
diabetes self-management [22].
Other underlying factors associated with poor man-
agement of diabetes patients was lack of diabetes screen-
ing programs, shortages of endocrinologists in more
remote regions of Armenia and high social stigma asso-
ciated with diabetes and insulin-use, especially among
younger diabetes patients. Absence of comprehensive
diabetes registry and lack of coordination of care be-
tween primary, secondary and tertiary level medical cen-
ters threatens the quality of diabetes care and puts
patients at greater risk for complications [22].
The aim of the current study was to describe the
prevalence of diabetic retinopathy and risk factors asso-




Diabetic patients from urban and rural areas in Armenia
register in primary health care (PHC) facilities for regu-
lar care and for receiving state guaranteed diabetes treat-
ment [22]. All registered diabetic patients from five
cities (Sevan, Gavar, Martuni, Tchambarak and Vardenis)
and 56 out of 87 villages in Gegharkunik province were
invited to their respective facilities for ophthalmic exam-
ination with the focus on detection of diabetic retinop-
athy. The endocrinologists working at the primary
health care facilities invited the patients for screenings
by phone. From 1,329 registered diabetics in Gegharkunik
province 625 participated in the eye screenings and inter-
views. The response rate was 47.0%. Data were collected
during July - December, 2012.
Instrument
The research team developed a structured questionnaire
for face to face interviews with diabetic patients. The
questionnaire included questions about demographic
data, disease history, health status in terms of having
chronic conditions, family history of diabetes, and
health-related behaviors. The research team used the
Diabetes Specific Scale designed by Stanford Patients
Education Research Center [24] as a base for developing
the questionnaire. The questionnaire was adapted, trans-
lated and pre-tested for use in Armenian population.
Study variables
The main outcome variable of interest in this study was
the presence of diabetic retinopathy (dichotomous).
Independent variables included age (continuous), gender
(dichotomous), urban/rural residence (dichotomous), edu-
cation (categorized as “incomplete secondary”, “secondary”,
“incomplete college/university” and “university/college”),
type of diabetes (dichotomous), participants’ body mass
Giloyan et al. BMC Ophthalmology  (2015) 15:46 Page 3 of 7index (BMI kg/m [2]) (categorized as normal weight
(BMI: 18.5-24.9), overweight (BMI: 25.0-29.9), mild or
class I obesity (BMI: 30.0-34.9), moderate or class II
obesity (BMI: 35.0-39.9) and severe or class III obesity
(BMI: >40)) [25], duration of diabetes in years (continu-
ous), being under insulin treatment (dichotomous), pres-
ence of chronic non-communicable diseases such as
hypertension, high cholesterol level, heart diseases, and
renal diseases (dichotomous), blood glucose level (con-
tinuous), use of medication for controlling diabetes and
blood pressure (dichotomous), current smoking status (di-
chotomous), and physical activity (dichotomous).
The blood glucose level was estimated based on the
patients’ recall of the latest result of their blood glucose
level.
Use of diabetes medication was assessed by asking
whether the patient took pills for diabetes in the past
week and use of blood pressure medication was assessed
by asking whether the patient took pills to control high
blood pressure in the past week.
Physical activity was assessed based on the physical
activity scale from the Behavioral Risk Factors Surveil-
lance System Questionnaire [26]. Participants were clas-
sified as physically active if they were moderately active
for at least five days per week with at least 30 minutes
per day, based on recommendations from the Centers
for Disease Control and Prevention (CDC) and the
American College of Sports Medicine [27,28].Eye screening procedure
All participants underwent detailed ophthalmologic
screening examination, including measurements of
visual acuity by Golovin-Sivtsev chart, cycloplegic skiascopy,
measurements of intraocular eye pressure (IOP) and dilated
eye fundus examination. Eye screenings were carries out by
the GMIPO team, which consists of two experienced
ophthalmologists, a nurse and an interviewer. DR was
assessed by dilated ophthalmoscopy and defined based on
the WHO International Classification of Diseases [29].
Nonproliferative diabetic retinopathy was diagnosed if
microaneurysm, hemorrhages, soft exudates, venous
beading and intraretinal microvascular abnormalities were
identified in retina. Pre-proliferative diabetic retinopathy
was diagnosed if new vessels were identified in retina and
definition not met for proliferative retinopathy. Prolifera-
tive diabetic retinopathy was diagnosed based on the for-
mation of new vessels at the disk (NVD) and elsewhere
(NVE). New vessels occur on or within optic disk about
one-quarter to one-third disk area, with or without vitreous
or pre-retinal hemorrhage. New vessels occur along the
border between healthy retina and areas of capillary
occlusion, on the iris and on the anterior hyaloid surface
[30,31]. Diabetic angiopathy was diagnosed if retinalischemia caused by capillary occlusion, retinal neovasculari-
zation and microaneurysms were identified in retina [32].
Ethical consideration
The study received approval from Institutional Review
Board of the American University of Armenia. Oral
consent was obtained from the patients. This study
adhered to the guidelines of the Declaration of Helsinki.
Analysis
The study team analyzed associations between risk
factors and having DR using logistic regression analysis.
Bivariate logistic regression identified factors signifi-
cantly associated with DR. The multivariate analysis
included all variables that were found to be associated
with DR at the p < 0.25 level in the bivariate analysis
[33] and the factors which have been shown to be
important for the development of DR in the literature.
Analysis included descriptive statistics, unadjusted
logistic regression, multivariate logistic regression and
testing of collinearity. Data were analyzed using SPSS
version 17.0 (SPSS Inc., Chicago, IL, USA).
Results
Demographic characteristics of respondents
Mean age of participants was 61.34 (SD = 11.01), ranging
from 15 to 88 years. Females comprised 64.3% of the
sample. We compared the age and sex distribution of
our sample to that of the total population of diabetics in
Gegharkunik province. The mean age of all diabetic
patients in Gegharkunik province was 59.99 (SD = 11.17)
and females comprised 57.6% of that population.
About 11.4% of the sample had higher education
(university/college), 17.5% had “incomplete university/
college”, 47.7% had “secondary”, and 23.3% had “incom-
plete secondary” education. Overall, 43.2% of partici-
pants were from urban and 56.8% from rural areas.
Prevalence of DR and other health status characteristics
The overall prevalence of DR in the sample was 36.2%
(Table 1). Age and gender standardized prevalence of
DR considering all registered patients with diabetes in
Gegharkunik province was 35.4%. A total of 90.2% of the
patients with DR had non-proliferative DR, and 9.8% of
them had proliferative DR. Pre-proliferative DR (moder-
ately to very severe non-proliferative DR) was diagnosed
in 31.7% of 202 individuals with non-proliferative DR.
Diabetic angiopathy was prevalent in 18.4% of diabetic
patients. Eleven percent of diabetic patients had macular
degeneration.
About 62.9% of the patients did not know about the
type of diabetes they had. Among those who knew, 2.9%
had type 1, and 34.2% had type 2 diabetes. On average,
patients have had diabetes for 7 years (SD = 6.0). About
Table 1 Respondents’ health status characteristics
% (N) 95% CI
Diabetic Retinopathy 36.2 (224) (32; 40)
Non- proliferative 90.2 (202) (86; 94)
Pre-proliferative 31.7 (64) (25; 38)
Proliferative 9.8 (22) (96; 99)
Eye diseases
Macular degeneration 11.0 (69) (8;13)
Diabetic angiopathy 18.4 (115) (15; 21)
Types of diabetes
Type 1 2.9 (18) (2; 4)
Type 2 34.2 (214) (30; 38)
Do not know 62.9 (393) (59; 67)
Years of having diabetes Mean (SD)
7 (6.0)
BMI (kg/m2)
Normal weight 17.9 (104) (15; 21)
Overweight 35.3 (205) (31; 39)
Mild or class I obesity 32.9 (191) (0.29; 0.37)
Moderate or class II obesity 10.8 (63) (0.08; 0.13)
Severe or class III obesity 3.1 (18) (0.02; 0.04)
Family history of having diabetes
Yes 53.1 (330) (49; 57)
No 46.9 (292) (43; 50)
Chronic disease
Hypertension 66.3 (413) (63; 70)
Heart disease 43.3 (270) (40; 47)
Renal disease 28.7 (179) (25; 32)
High cholesterol level 22.0 (137) (20; 25)
Self-reported health
Excellent 0.6 (4) (0.3; 0.9)
Very good 0.3 (2) (−0.1; 0.7)
Good 14.3 (89) (11; 17)
Satisfactory 58.4 (363) (55; 61)
Bad 26.4 (164) (23; 30)
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overweight, 32.9% had mild or class I obesity, 10.8% had
moderate or class II obesity and 3.1% had severe or class
III obesity. About 53% of respondents mentioned having
diabetes among first degree relatives.
Hypertension was the most prevalent chronic condi-
tion, with 66.3% of the respondents suffering from it.
High cholesterol level was reported by 22.0%. Most of
the patients (58.4%) described their overall health status
as “satisfactory”, 26.4% described it as “bad”, 14.3% as
“good”, 0.6% as “excellent”, and 0.3% as “very good”.Self-reported use of medication, physical activity and
smoking
Ninety six percent of the study population reported that
they took pills to control diabetes in the past week and
84.2% of study participants reported taking pills to con-
trol high blood pressure in the past week. About half of
the patients (51.2%) were physically active and only 8.0%
reported smoking currently.
Logistic regression analysis of risk factors associated with
diabetic retinopathy
The bivariate logistic regression showed that age, being
overweight, diabetes duration, being under insulin treat-
ment, blood glucose level, having non-communicable
diseases (hypertension, renal and heart diseases) were
significantly associated with DR. Unadjusted analysis
showed no significant association between DR and type
of diabetes, gender, age at the onset of diabetes, BMI,
high cholesterol level, use of medication for controlling
diabetes, smoking, and physical activity.
In the adjusted analysis age, diabetes duration and being
under insulin treatment were associated with diabetic ret-
inopathy (Table 2). The odds of having DR increased by
5.0% with each additional year of age (OR = 1.05; 95% CI:
1.02 – 1.08) after adjusting for other covariates. Each add-
itional year of diabetes duration was associated with 23.0%
higher odds of having DR (OR = 1.23; 95% CI: 1.16 –
1.31). Adjusted odds of having DR were 3.24 times higher
among those who were treated with insulin compared to
patients treated with other glucose controlling medication
(OR = 3.24; 95% CI: 1.56 – 6.75). The effects of other
factors such as current blood glucose level, having non-
communicable diseases dissipated in the adjusted model.
Discussion
This study provides unique data on the prevalence of dia-
betic retinopathy and the associated factors in one of the
regions of Armenia – a country for which no information
on DR have been previously available in the literature. The
study showed that the prevalence of diabetic retinopathy
was 36.2% among diabetic patients in Gegharkunik region.
The prevalence of DR in this population was similar to or
lower than the rates that were found in other countries in
the region, including Iran (37.0% of diabetic patients) [34]
and Russia (46.0% of diabetic patients) [35]. Various stud-
ies report different rates of DR worldwide, with the esti-
mates largely depending on the methodology, setting,
diagnostic method, and the population sample [18]. The
prevalence of DR among diabetic patients reported in a
large study conducted in the US was 33.2% [15], while the
studies conducted in Norway and the UK report substan-
tially lower prevalence of DR, 13.0% and 29.4%, respectev-
ily [10,11]. The study by Thomas et al. conducted in the
UK among 57,199 diabetic patients reported 29.4%
Table 2 The risk factors for diabetic retinopathy: Results of unadjusted and adjusted logistic regression
Unadjusted OR (95% CI) Unadjusted p-value Adjusted OR (95% CI) Adjusted p-value
Age (in years) 1.04 (1.02; 1.05) 0.00 1.05 (1.02; 1.08) 0.00
Gender
Female 1.00 1.00
Male 0.95 (0.67; 1.34) 0.76 0.96 (0.53; 1.74) 0.89
BMI (kg/m2)
Normal 1.00 1.00
Overweight/Obese 1.23 (0.78; 1.93) 0.38 1.76 (0.86; 3.58) 0.12
Diabetes duration (in years) 1.23 (1.18; 1.28) 0.00 1.23 (1.16; 1.31) 0.00
Being under insulin treatment 3.36 (2.25; 5.04) 0.00 3.24 (1.56; 6.75) 0.00
Current blood glucose level 1.05 (1.02; 1.09) 0.00 0.98 (0.93; 1.05) 0.63
Non-communicable diseases* 1.83 (1.20; 2.77) 0.00 1.10 (0.57; 2.14) 0.77
Smoking 0.84 (0.45; 1.57) 0.41 0.64 (0.18; 2.22) 0.48
Physical activity 0.87 (0.57; 1.32) 0.51 1.10 (0.65; 1.88) 0.71
*Hypertension, heart diseases and renal diseases.
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et al. based on data from 35 studies in different countries
(1980–2008) from 22,896 individuals with diabetes
showed that the global prevalence of DR was 34.6% [36],
while the study by Ruta et al. showed 27.9% (22-37%) me-
dian prevalence of diabetic retinopathy in 33 developed
and developing countries [37]. The slightly higher preva-
lence of DR in Armenia might be explained by lack of
preventive efforts among Armenian diabetic patients such
as regular screenings and patient counseling about
diabetic retinopathy and its prevention and control. These
problems might be typical for other countries of Eastern
Europe, where lack of systematic screenings for eye com-
plications in diabetes patients, particularly in rural areas,
has been highlighted [38,39].
The risk factors that were shown to have significant
and independent associations with diabetic retinopathy
in the multivariate analysis in this study included age,
duration of diabetes and being under insulin treatment.
The duration of diabetes in the present study was
strongly associated with DR. About 76.7% of patients
who suffered from diabetes for more than 20 years were
diagnosed with DR. Aiello et al. reported that after
20 years of diabetes, more than 60 percent of type 2 dia-
betes patients will have retinopathy regardless of the dia-
betic control [40]. This have been confirmed by
numerous other studies [9,10,12,14]. Studies suggest that
duration of diabetes might reflect total glycemic control
and exposure to other risk factors over time [18,40].
With age, chances of getting DR increase in diabetic
patients; [17] also, the increasing age contributes signifi-
cantly to the severity of DR [6,12]. In this study we re-
corded limited effect of age with marginal significance.
Some authors suggest that age might be a surrogate
marker of duration of DR in patients [41].Being under insulin treatment was the strongest risk fac-
tor for DR among the participants of this study, with odds
of having DR being 2.35 times higher among those who
were treated with insulin compared to patients treated
with other glucose controlling medication. This finding
was consistent with other studies [6,11,12,42]. Although
some authors assume that being on insulin treatment
might be related to the duration of the disease [43], in our
study the effect of insulin was present even after control-
ling for the duration of diabetes. Younis et al. reported
that patients using insulin were at higher risk of progres-
sion to sight-threatening diabetic retinopathy in the longi-
tudinal Liverpool Diabetic Eye Study [42]. The authors
suggested that the need for insulin treatment might reflect
poorer metabolic control in such patients.
Several epidemiological studies examined the relation-
ship of BMI and DR and found inconsistent results
[8,13,41,44-48]. Most studies show positive association
between high BMI or obesity with DR [8,13,44], while
other studies reported contradictory findings [41,45-48].
Our study found positive but not statistically significant
association between overweight/obesity with DR.
Having chronic non-communicable diseases (hyper-
tension, renal and heart diseases) and self-reported high
blood glucose level were not significantly associated with
DR in the multivariate analysis. Most studies show that
high blood pressure is significantly associated with DR
[7,9,17]. It is possible that our analysis failed to reveal
the association between chronic non-communicable
diseases and DR because we used self-reported data on
these conditions instead of the data obtained from med-
ical records. The same concern is valid for the blood
glucose level. In our study, the patients were asked to
recall the latest result of their blood glucose level; how-
ever, their recall might have been inaccurate and might
Giloyan et al. BMC Ophthalmology  (2015) 15:46 Page 6 of 7have biased the results of the analysis. Our decision to
rely on self-reported data was largely conditioned by
the difficulties to obtain reliable and detailed records
on the indicators of interest from the local primary
healthcare facilities.
Our study has several limitations. First, the prevalence
statistics reported in our study is based on the sample of
diabetic patients who were registered in primary health-
care facilities in Gegharkunik province and who agreed to
participate in the screening with the response rate of 47%.
It is possible that those who refused or were unable to
participate were systematically different from those who
were included in the study, particularly in terms of their
diabetes status and vision problems. Second, our study
used clinical examination for diagnosing cases with
diabetic retinopathy instead of performing stereoscopic
fundus photography and did not assess inter- and intra-
observer agreement on diagnoses of diabetic retinopathy.
Some of the risk factor variables which were used in the
study, including health status, chronic non-communicable
diseases, blood glucose level, years of having diabetes,
smoking and physical activities were based on self-report
of the patients due to absence of quality measurements
from local laboratories for all patients who were involved
in the study, which might have introduced a recall bias.Conclusion
This study found high prevalence of DR among Armenian
diabetic patients. Age, diabetes duration, being overweight
and being under insulin treatment were independently
associated with diabetic retinopathy. Our findings warrant
increased efforts by policy makers and health care
providers in Armenia to ensure timely diagnosis of DR
and better control of factors associated with DR among
diabetic patients.
Population-based educational programs on diabetes
and diabetic retinopathy and continuous medical educa-
tion trainings in diabetes management can improve dia-
betes care and self-management and prevent eye
complications.
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